Vyhnalek Martin, Magerova Hana, Andel Ross, Nikolai Tomas, Kadlecova Alexandra, Laczo Jan, Hort Jakub
International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic; Memory Clinic, Department of Neurology, Charles University in Prague, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic.
Memory Clinic, Department of Neurology, Charles University in Prague, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic.
J Neurol Sci. 2015 Feb 15;349(1-2):179-84. doi: 10.1016/j.jns.2015.01.014. Epub 2015 Jan 14.
Olfactory identification impairment in amnestic mild cognitive impairment (aMCI) patients is well documented and considered to be caused by underlying Alzheimer's disease (AD) pathology, contrasting with less clear evidence in non-amnestic MCI (naMCI). The aim was to (a) compare the degree of olfactory identification dysfunction in aMCI, naMCI, controls and mild AD dementia and (b) assess the relation between olfactory identification and cognitive performance in aMCI compared to naMCI.
75 patients with aMCI and 32 with naMCI, 26 patients with mild AD and 27 controls underwent the multiple choice olfactory identification Motol Hospital Smell Test with 18 different odors together with a comprehensive neuropsychological examination.
Controlling for age and gender, patients with aMCI and naMCI did not differ significantly in olfactory identification and both performed significantly worse than controls (p<0.001), albeit also better than patients with mild AD (p<.001). In the aMCI group, higher scores on MMSE, verbal and non-verbal memory and visuospatial tests were significantly related to better olfactory identification ability. Conversely, no cognitive measure was significantly related to olfactory performance in naMCI.
Olfactory identification is similarly impaired in aMCI and naMCI. Olfactory impairment is proportional to cognitive impairment in aMCI but not in naMCI.
遗忘型轻度认知障碍(aMCI)患者的嗅觉识别受损已有充分记录,并被认为是由潜在的阿尔茨海默病(AD)病理所致,而非遗忘型MCI(naMCI)的相关证据则不太明确。目的是(a)比较aMCI、naMCI、对照组和轻度AD痴呆患者的嗅觉识别功能障碍程度,以及(b)评估aMCI与naMCI相比,嗅觉识别与认知表现之间的关系。
75例aMCI患者、32例naMCI患者、26例轻度AD患者和27名对照者接受了包含18种不同气味的多项选择嗅觉识别莫托医院嗅觉测试,并进行了全面的神经心理学检查。
在控制年龄和性别后,aMCI和naMCI患者在嗅觉识别方面无显著差异,且两者的表现均显著差于对照组(p<0.001),不过也优于轻度AD患者(p<.001)。在aMCI组中,简易精神状态检查表(MMSE)、言语和非言语记忆以及视觉空间测试得分较高与更好的嗅觉识别能力显著相关。相反,在naMCI中,没有认知指标与嗅觉表现显著相关。
aMCI和naMCI患者的嗅觉识别同样受损。嗅觉障碍在aMCI中与认知障碍成正比,但在naMCI中并非如此。